Total Payments
$18,248
2024 Payments
$167.46
Companies
89
Transactions
1,027
Medicare Patients
7,399
Medicare Billing
$3.1M
Payment Breakdown by Category
Food & Beverage$17,371 (95.2%)
Education$877.39 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,371 | 1,010 | 95.2% |
| Education | $877.39 | 17 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,344 | 95 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,268 | 70 | $0 (2024) |
| Amgen Inc. | $1,130 | 56 | $0 (2022) |
| Merck Sharp & Dohme LLC | $1,013 | 62 | $0 (2022) |
| Astellas Pharma US Inc | $977.29 | 53 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $942.93 | 87 | $0 (2022) |
| Genentech USA, Inc. | $827.16 | 61 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $684.24 | 33 | $0 (2023) |
| PFIZER INC. | $563.55 | 55 | $0 (2022) |
| Octapharma USA, Inc. | $548.80 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $167.46 | 7 | Daiichi Sankyo Inc. ($97.48) |
| 2023 | $379.28 | 15 | Avanos Medical ($86.82) |
| 2022 | $973.62 | 41 | Karyopharm Therapeutics Inc. ($184.05) |
| 2021 | $3,843 | 181 | Novartis Pharmaceuticals Corporation ($299.41) |
| 2020 | $2,544 | 149 | Amgen Inc. ($292.27) |
| 2019 | $3,896 | 220 | Octapharma USA, Inc. ($428.05) |
| 2018 | $3,319 | 211 | Novartis Pharmaceuticals Corporation ($329.80) |
| 2017 | $3,125 | 203 | Genentech USA, Inc. ($337.03) |
All Payment Transactions
1,027 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.04 | General |
| 08/28/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/02/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: ONCOLOGY | ||||||
| 01/22/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: ONCOLOGY | ||||||
| 12/29/2023 | CSL Behring | Afstyla (Biological), Idelvion | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Hematology | ||||||
| 07/20/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2023 | Avanos Medical | ON-Q* PUMP AND ACCESSORIES (Device) | Food and Beverage | In-kind items and services | $86.82 | General |
| Category: SURGICAL PAIN | ||||||
| 07/10/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/05/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $19.71 | General |
| 06/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Oncology | ||||||
| 04/13/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: ONCOLOGY | ||||||
| 03/31/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2023 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Oncology | ||||||
| 03/17/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: HORMONE THERAPY | ||||||
| 02/16/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Oncology | ||||||
| 02/10/2023 | TerSera Therapeutics LLC | Xermelo (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Oncology | ||||||
| 01/31/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Oncology | ||||||
| 01/09/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ONCOLOGY | ||||||
| 12/28/2022 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 11/28/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 12 | 692 | 8,769 | $484,120 | $145,512 |
| 2021 | 36 | 3,498 | 137,935 | $5.3M | $1.7M |
| 2020 | 32 | 3,209 | 121,871 | $2.6M | $1.3M |
Total Patients
7,399
Total Services
268,575
Medicare Billing
$3.1M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 133 | 8,100 | $406,944 | $123,940 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 114 | 118 | $39,793 | $10,842 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 67 | $15,933 | $4,194 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 145 | 172 | $6,386 | $2,072 | 32.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 16 | 23 | $4,455 | $1,364 | 30.6% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2022 | 20 | 20 | $2,817 | $1,071 | 38.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 62 | 83 | $2,075 | $644.67 | 31.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 11 | 25 | $1,461 | $456.86 | 31.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 41 | 42 | $2,310 | $443.08 | 19.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 11 | 26 | $1,164 | $255.37 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 64 | 73 | $730.00 | $218.88 | 30.0% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 11 | 20 | $51.40 | $10.20 | 19.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 525 | 52,380 | $2.6M | $838,181 | 31.9% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2021 | 11 | 8,900 | $1.1M | $367,186 | 32.1% |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2021 | 21 | 5,780 | $604,867 | $192,126 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 482 | 734 | $240,585 | $77,293 | 32.1% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2021 | 42 | 7,220 | $155,854 | $47,803 | 30.7% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 23 | 38,250 | $103,534 | $34,426 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 320 | 442 | $101,279 | $32,403 | 32.0% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 54 | 152 | $58,498 | $19,094 | 32.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 585 | 1,123 | $41,357 | $13,352 | 32.3% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2021 | 18 | 17,850 | $43,170 | $12,935 | 30.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 74 | 199 | $37,958 | $12,194 | 32.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 38 | 47 | $21,263 | $6,845 | 32.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 292 | 746 | $18,650 | $5,768 | 30.9% |
About Dr. David Young, M.D
Dr. David Young, M.D is a Hematology & Oncology healthcare provider based in Rancho Mirage, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427069350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Young, M.D has received a total of $18,248 in payments from pharmaceutical and medical device companies, with $167.46 received in 2024. These payments were reported across 1,027 transactions from 89 companies. The most common payment nature is "Food and Beverage" ($17,371).
As a Medicare-enrolled provider, Young has provided services to 7,399 Medicare beneficiaries, totaling 268,575 services with total Medicare billing of $3.1M. Data is available for 3 years (2020–2022), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Rancho Mirage, CA
- Active Since 08/09/2006
- Last Updated 05/28/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1427069350
Products in Payments
- KEYTRUDA (Biological) $830.88
- OPDIVO (Biological) $782.21
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) $428.05
- IMBRUVICA (Drug) $419.60
- Imbruvica (Drug) $415.51
- IMFINZI (Drug) $384.58
- XTANDI (Drug) $312.38
- MONJUVI (Drug) $304.17
- FOUNDATIONONE (Device) $294.27
- Kyprolis (Biological) $261.12
- BRUKINSA (Drug) $260.84
- Avastin (Biological) $257.01
- MEKINIST (Drug) $256.29
- KISQALI (Drug) $253.16
- XPOVIO (Drug) $249.94
- TAGRISSO (Drug) $241.03
- LYNPARZA (Drug) $238.46
- DARZALEX (Biological) $232.73
- BENDEKA (Drug) $222.88
- Nplate (Biological) $210.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Rancho Mirage
Dr. Henry Tsai, M.d, M.D
Hematology & Oncology — Payments: $43,294
Hematology & Oncology $43,294
Dr. Mark Carmichael, Md, MD
Hematology & Oncology — Payments: $30,629
Hematology & Oncology $30,629
Dr. Amy Law, M.d, M.D
Hematology & Oncology — Payments: $29,093
Hematology & Oncology $29,093
Luke Dreisbach, M.d, M.D
Hematology & Oncology — Payments: $23,138
Hematology & Oncology $23,138
Philip Dreisbach, M.d, M.D
Hematology & Oncology — Payments: $21,630
Hematology & Oncology $21,630
Dr. Kota Shekar, Md, MD
Hematology & Oncology — Payments: $20,807
Hematology & Oncology $20,807